{"transactions":[{"id":739751,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:01:20.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on October 1, 2026, January 1, 2027, and April 1, 2027, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 11, 2026 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":70000,"derivative":{"exercise_price":1.14,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001746473-26-000103","document":"wk-form4_1781298078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000174647326000103/wk-form4_1781298078.xml","form_type":"4"}},{"id":846030,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-12T16:05:04.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":409836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":1898838,"source":{"system":"sec-edgar","filing":"0001193125-26-104099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000119312526104099/ownership.xml","form_type":"4"}},{"id":881892,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:07.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":103526,"price":3.66,"value":378905.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":1489002,"source":{"system":"sec-edgar","filing":"0001193125-26-071496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000119312526071496/ownership.xml","form_type":"4"}},{"id":881891,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:07.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":94757,"price":3.81,"value":361024.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 4 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2025."}],"balance_after":1592528,"source":{"system":"sec-edgar","filing":"0001193125-26-071496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000119312526071496/ownership.xml","form_type":"4"}},{"id":1117830,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-09T20:44:23.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively,  and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":30000,"derivative":{"exercise_price":1.61,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001746473-25-000130","document":"wk-form4_1749516254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000174647325000130/wk-form4_1749516254.xml","form_type":"4"}},{"id":1140384,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-20T16:14:00.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":1687281,"source":{"system":"sec-edgar","filing":"0000950170-25-075191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025075191/ownership.xml","form_type":"4"}},{"id":1140383,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-20T16:14:00.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":13353,"price":0.58,"value":7744.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1147281,"source":{"system":"sec-edgar","filing":"0000950170-25-075191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025075191/ownership.xml","form_type":"4"}},{"id":1271592,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-12T21:00:11.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":139064,"price":1.76,"value":244752.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":1160634,"source":{"system":"sec-edgar","filing":"0000950170-25-019237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025019237/ownership.xml","form_type":"4"}},{"id":1297451,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-22T16:35:33.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":147354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 8, 2022. The earned PSUs were certified and vested on January 17, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024."}],"balance_after":1299698,"source":{"system":"sec-edgar","filing":"0000950170-25-007805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025007805/ownership.xml","form_type":"4"}},{"id":1477261,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-17T20:16:39.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":26764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 13th, 2024 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 13, 2024 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":26764,"derivative":{"exercise_price":13.06,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":26764},"source":{"system":"sec-edgar","filing":"0001746473-24-000108","document":"wk-form4_1718669792.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000174647324000108/wk-form4_1718669792.xml","form_type":"4"}},{"id":1505404,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-22T16:05:26.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":67618,"price":6.45,"value":436136.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1150330,"source":{"system":"sec-edgar","filing":"0000950170-24-063485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024063485/ownership.xml","form_type":"4"}},{"id":1581010,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T16:05:07.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":120298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":120298},"source":{"system":"sec-edgar","filing":"0000950170-24-029909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024029909/ownership.xml","form_type":"4"}},{"id":1581009,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-12T16:05:07.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":120298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":1217948,"source":{"system":"sec-edgar","filing":"0000950170-24-029909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024029909/ownership.xml","form_type":"4"}},{"id":1589057,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-07T16:05:10.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":132438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."}],"balance_after":132438,"derivative":{"expiration_date":"2027-02-28","underlying":"Class A Common Stock","underlying_shares":132438},"source":{"system":"sec-edgar","filing":"0000950170-24-027917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024027917/ownership.xml","form_type":"4"}},{"id":1589056,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-07T16:05:10.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":264876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":1097650,"source":{"system":"sec-edgar","filing":"0000950170-24-027917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024027917/ownership.xml","form_type":"4"}},{"id":1643117,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-14T20:35:15.000Z","date":"2024-02-12","kind":"sale","planned":false,"acquired":false,"shares":177164,"price":15.24,"value":2699979.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":832774,"source":{"system":"sec-edgar","filing":"0000950170-24-015542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024015542/ownership.xml","form_type":"4"}},{"id":1675161,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-19T16:05:33.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":249617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 26, 2021 and June 7, 2021. The earned PSUs were certified and vested on January 17, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 2,037 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2023."}],"balance_after":1009938,"source":{"system":"sec-edgar","filing":"0001209191-24-001906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919124001906/doc4.xml","form_type":"4"}},{"id":1862178,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T17:22:24.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 7th, 2023 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 7th, 2023 grant date, or (ii) the 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":14000,"derivative":{"exercise_price":23.09,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-035535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123035535/doc4.xml","form_type":"4"}},{"id":1871848,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-01T17:45:39.000Z","date":"2023-05-30","kind":"sale","planned":true,"acquired":false,"shares":26632,"price":10.7,"value":284962.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $10.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":758284,"source":{"system":"sec-edgar","filing":"0001209191-23-033396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123033396/doc4.xml","form_type":"4"}},{"id":1879664,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-24T16:05:23.000Z","date":"2023-05-22","kind":"sale","planned":false,"acquired":false,"shares":36000,"price":10.12,"value":364320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":784916,"source":{"system":"sec-edgar","filing":"0001209191-23-031875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123031875/doc4.xml","form_type":"4"}},{"id":1898097,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-10T16:05:07.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":21148,"price":10.62,"value":224591.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.59 to $10.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":820916,"source":{"system":"sec-edgar","filing":"0001209191-23-028453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123028453/doc4.xml","form_type":"4"}},{"id":1935665,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-29T16:05:23.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":46129,"price":10.67,"value":492196.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.58 to $10.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this\nfootnote."}],"balance_after":842064,"source":{"system":"sec-edgar","filing":"0001209191-23-021524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123021524/doc4.xml","form_type":"4"}},{"id":1958687,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2023-03-10T17:09:42.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":120297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."}],"balance_after":120297,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":120297},"source":{"system":"sec-edgar","filing":"0001209191-23-017882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123017882/doc4.xml","form_type":"4"}},{"id":1958686,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-10T17:09:42.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":240595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":888193,"source":{"system":"sec-edgar","filing":"0001209191-23-017882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123017882/doc4.xml","form_type":"4"}},{"id":1963196,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T16:42:42.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 6, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":22000,"derivative":{"exercise_price":31.11,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-23-017217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123017217/doc4.xml","form_type":"4"}},{"id":1965725,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-07T16:05:30.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":33756,"price":11.22,"value":378742.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":647598,"source":{"system":"sec-edgar","filing":"0001209191-23-016696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123016696/doc4.xml","form_type":"4"}},{"id":1983545,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-01T18:22:25.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":4588,"price":11.31,"value":51890.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":681354,"source":{"system":"sec-edgar","filing":"0001209191-23-014283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123014283/doc4.xml","form_type":"4"}},{"id":1983544,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-01T18:22:25.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":26639,"price":11.31,"value":301287.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":685942,"source":{"system":"sec-edgar","filing":"0001209191-23-014283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123014283/doc4.xml","form_type":"4"}},{"id":1983543,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-01T18:22:25.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":4409,"price":11.41,"value":50306.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":712581,"source":{"system":"sec-edgar","filing":"0001209191-23-014283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123014283/doc4.xml","form_type":"4"}},{"id":1983542,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-01T18:22:25.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":25595,"price":11.41,"value":292038.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":716990,"source":{"system":"sec-edgar","filing":"0001209191-23-014283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123014283/doc4.xml","form_type":"4"}},{"id":2050787,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-19T16:05:13.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":30145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted February 27, 2020. The earned PSUs were certified and vested on January 17, 2023."}],"balance_after":742585,"source":{"system":"sec-edgar","filing":"0001209191-23-003990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123003990/doc4.xml","form_type":"4"}},{"id":2058776,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-01-09T16:05:16.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":110962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options, vested as to 1.25% on each monthly anniversary of the vesting commencement date for the first 36 months, and as to 4.5833% of the award on each monthly anniversary thereafter, are presently exercisable in full."}],"balance_after":0,"derivative":{"exercise_price":11.65,"expiration_date":"2023-02-01","underlying":"Class A Common Stock","underlying_shares":110962},"source":{"system":"sec-edgar","filing":"0001209191-23-002543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123002543/doc4.xml","form_type":"4"}},{"id":2058775,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-09T16:05:16.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":110962,"price":12.07,"value":1339311.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $12.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":712440,"source":{"system":"sec-edgar","filing":"0001209191-23-002543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123002543/doc4.xml","form_type":"4"}},{"id":2058774,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-09T16:05:16.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":110962,"price":11.65,"value":1292707.3,"ownership":{"direct":true},"balance_after":823402,"source":{"system":"sec-edgar","filing":"0001209191-23-002543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919123002543/doc4.xml","form_type":"4"}},{"id":2142158,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-05T16:05:39.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":18899,"price":10.41,"value":196738.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.25 to $10.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":712440,"source":{"system":"sec-edgar","filing":"0001209191-22-052718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122052718/doc4.xml","form_type":"4"}},{"id":2165553,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-06T16:05:55.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":26446,"price":10.65,"value":281649.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.59 to $10.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":731339,"source":{"system":"sec-edgar","filing":"0001209191-22-048716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122048716/doc4.xml","form_type":"4"}},{"id":2195732,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-03T16:05:36.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":23229,"price":11.35,"value":263649.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.30 to $11.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 2,092 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":757785,"source":{"system":"sec-edgar","filing":"0001209191-22-044162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122044162/doc4.xml","form_type":"4"}},{"id":2214607,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-05T16:05:34.000Z","date":"2022-06-30","kind":"sale","acquired":false,"shares":19959,"price":11.58,"value":231125.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":778922,"source":{"system":"sec-edgar","filing":"0001209191-22-040558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122040558/doc4.xml","form_type":"4"}},{"id":2256711,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-25T16:05:40.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":11848,"price":11.5,"value":136252.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on June 7, 2021."}],"balance_after":798881,"source":{"system":"sec-edgar","filing":"0001209191-22-031844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122031844/doc4.xml","form_type":"4"}},{"id":2256710,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-25T16:05:40.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":21873,"price":11.5,"value":251539.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 50% of the reporting person's restricted stock units granted on March 26, 2021."}],"balance_after":810729,"source":{"system":"sec-edgar","filing":"0001209191-22-031844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122031844/doc4.xml","form_type":"4"}},{"id":2256709,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-25T16:05:40.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":2587,"price":11.5,"value":29750.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019."}],"balance_after":832602,"source":{"system":"sec-edgar","filing":"0001209191-22-031844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122031844/doc4.xml","form_type":"4"}},{"id":2339764,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-10T16:05:30.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":248869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":835189,"source":{"system":"sec-edgar","filing":"0001209191-22-017840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122017840/doc4.xml","form_type":"4"}},{"id":2360466,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-02T16:01:19.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":16486,"price":10.77,"value":177554.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 22, 2021."}],"balance_after":586320,"source":{"system":"sec-edgar","filing":"0001209191-22-014653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122014653/doc4.xml","form_type":"4"}},{"id":2360465,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-02T16:01:19.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":19970,"price":10.77,"value":215076.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting of the reporting person's performance-based restricted stock units granted on February 27, 2020."}],"balance_after":602806,"source":{"system":"sec-edgar","filing":"0001209191-22-014653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122014653/doc4.xml","form_type":"4"}},{"id":2360464,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-02T16:01:19.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":10026,"price":10.77,"value":107980.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020."}],"balance_after":622776,"source":{"system":"sec-edgar","filing":"0001209191-22-014653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122014653/doc4.xml","form_type":"4"}},{"id":2360463,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-02T16:01:19.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":1942,"price":10.77,"value":20915.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018."}],"balance_after":632802,"source":{"system":"sec-edgar","filing":"0001209191-22-014653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919122014653/doc4.xml","form_type":"4"}},{"id":2428744,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-21T17:54:23.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":60290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs)\ngranted February 27, 2020. The earned PSUs were certified and vested on January 19, 2022."}],"balance_after":634744,"source":{"system":"sec-edgar","filing":"0001104659-22-006548","document":"tm224209-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000110465922006548/tm224209-1_4seq1.xml","form_type":"4"}},{"id":2459561,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-23T16:18:28.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":46327,"price":11.41,"value":528591.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.28 to $11.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 2,236 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2021."}],"balance_after":574454,"source":{"system":"sec-edgar","filing":"0001209191-21-071074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121071074/doc4.xml","form_type":"4"}},{"id":2495198,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-24T16:09:27.000Z","date":"2021-11-23","kind":"sale","acquired":false,"shares":52644,"price":11.58,"value":609617.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 100% of the reporting person's restricted stock units granted on December 16, 2019."}],"balance_after":618545,"source":{"system":"sec-edgar","filing":"0001209191-21-066783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121066783/doc4.xml","form_type":"4"}},{"id":2500702,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-11-22T09:08:56.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":3222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."}],"balance_after":0,"derivative":{"exercise_price":115.53,"underlying":"Common Stock","underlying_shares":3222},"source":{"system":"sec-edgar","filing":"0001104659-21-142275","document":"tm2133601-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000110465921142275/tm2133601-9_4seq1.xml","form_type":"4"}},{"id":2500701,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-11-22T09:08:56.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":8185,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."}],"balance_after":0,"derivative":{"exercise_price":52.99,"underlying":"Common Stock","underlying_shares":8185},"source":{"system":"sec-edgar","filing":"0001104659-21-142275","document":"tm2133601-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000110465921142275/tm2133601-9_4seq1.xml","form_type":"4"}},{"id":2500700,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-11-22T09:08:56.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested immediately prior to the Effective Time vested in full. As of the Effective Time, each Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option was entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable tax withholdings) equal to the product of (x) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option."}],"balance_after":0,"derivative":{"exercise_price":41.64,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-21-142275","document":"tm2133601-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000110465921142275/tm2133601-9_4seq1.xml","form_type":"4"}},{"id":2500699,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T09:08:56.000Z","date":"2021-11-19","kind":"other","acquired":false,"shares":6044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 29, 2021, by and among the Issuer, Merck Sharp & Dohme Corp. (\"Parent\"), and Astros Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 19, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $180.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 29, 2021, by and among the Issuer, Merck Sharp & Dohme Corp. (\"Parent\"), and Astros Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 19, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $180.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 29, 2021, by and among the Issuer, Merck Sharp & Dohme Corp. (\"Parent\"), and Astros Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 19, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $180.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-142275","document":"tm2133601-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000110465921142275/tm2133601-9_4seq1.xml","form_type":"4"}},{"id":2675563,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-09T16:02:18.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":104690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a new Chief Executive Officer award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":671189,"source":{"system":"sec-edgar","filing":"0001209191-21-039159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121039159/doc4.xml","form_type":"4"}},{"id":2695093,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Interim CEO"}}],"security":"Class A Common Stock","published_at":"2021-05-26T16:01:29.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":1716,"price":12.25,"value":21021.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019."}],"balance_after":566499,"source":{"system":"sec-edgar","filing":"0001209191-21-035896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121035896/doc4.xml","form_type":"4"}},{"id":2743028,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-04-21T16:46:11.000Z","date":"2021-04-19","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of common stock underlying this stock option award vested in full on the one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":40.61,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001179110-21-004537","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021004537/edgar.xml","form_type":"4"}},{"id":2743027,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:46:11.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":200,"price":121.23,"value":24246.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.15 to $121.30 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4."}],"balance_after":6044,"source":{"system":"sec-edgar","filing":"0001179110-21-004537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021004537/edgar.xml","form_type":"4"}},{"id":2743026,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:46:11.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":1143,"price":120.16,"value":137342.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.83 to $120.74 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":6244,"source":{"system":"sec-edgar","filing":"0001179110-21-004537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021004537/edgar.xml","form_type":"4"}},{"id":2743025,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:46:11.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":4030,"price":119.36,"value":481020.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.83 to $119.78 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":7387,"source":{"system":"sec-edgar","filing":"0001179110-21-004537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021004537/edgar.xml","form_type":"4"}},{"id":2743024,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:46:11.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":2127,"price":118.39,"value":251815.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.81 to $118.72 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":11417,"source":{"system":"sec-edgar","filing":"0001179110-21-004537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021004537/edgar.xml","form_type":"4"}},{"id":2743023,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:46:11.000Z","date":"2021-04-19","kind":"exercise","acquired":true,"shares":7500,"price":40.61,"value":304575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":13544,"source":{"system":"sec-edgar","filing":"0001179110-21-004537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021004537/edgar.xml","form_type":"4"}},{"id":2767942,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Interim CEO"}}],"security":"Class A Common Stock","published_at":"2021-03-30T17:07:38.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":96638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock units, granted as a retention award, vest as to 50% of the shares of Class A Common Stock on each of May 19, 2022 and May 18, 2023."}],"balance_after":568215,"source":{"system":"sec-edgar","filing":"0001209191-21-023573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121023573/doc4.xml","form_type":"4"}},{"id":2819947,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T16:40:18.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":10265,"price":9.11,"value":93514.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020."}],"balance_after":471577,"source":{"system":"sec-edgar","filing":"0001209191-21-016070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121016070/doc4.xml","form_type":"4"}},{"id":2819946,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T16:40:18.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1838,"price":9.11,"value":16744.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February\n21, 2018."}],"balance_after":481842,"source":{"system":"sec-edgar","filing":"0001209191-21-016070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121016070/doc4.xml","form_type":"4"}},{"id":2819945,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T16:40:18.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":2582,"price":9.11,"value":23522.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February\n27, 2017."}],"balance_after":483680,"source":{"system":"sec-edgar","filing":"0001209191-21-016070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121016070/doc4.xml","form_type":"4"}},{"id":2835822,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2021-02-24T16:07:13.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":145631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":486262,"source":{"system":"sec-edgar","filing":"0001209191-21-013751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919121013751/doc4.xml","form_type":"4"}},{"id":2885495,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-02-02T18:49:16.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":3222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest in full on the one year anniversary of the grant date."}],"balance_after":3222,"derivative":{"exercise_price":115.53,"expiration_date":"2031-01-29","underlying":"Common Stock","underlying_shares":3222},"source":{"system":"sec-edgar","filing":"0001179110-21-001112","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021001112/edgar.xml","form_type":"4"}},{"id":2885494,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T18:49:16.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6044,"source":{"system":"sec-edgar","filing":"0001179110-21-001112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911021001112/edgar.xml","form_type":"4"}},{"id":2942470,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-16T16:49:43.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":99988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted as an annual performance award, was exercisable in full."}],"balance_after":0,"derivative":{"exercise_price":9.89,"expiration_date":"2021-02-01","underlying":"Class A Common Stock","underlying_shares":99988},"source":{"system":"sec-edgar","filing":"0001209191-20-063819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120063819/doc4.xml","form_type":"4"}},{"id":2942469,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-12-16T16:49:43.000Z","date":"2020-12-14","kind":"tax_withholding","acquired":false,"shares":81089,"price":12.2,"value":989285.8,"ownership":{"direct":true},"balance_after":340631,"source":{"system":"sec-edgar","filing":"0001209191-20-063819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120063819/doc4.xml","form_type":"4"}},{"id":2942468,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-12-16T16:49:43.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":99988,"price":9.89,"value":988881.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person acquired 1,885 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2020."}],"balance_after":421720,"source":{"system":"sec-edgar","filing":"0001209191-20-063819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120063819/doc4.xml","form_type":"4"}},{"id":3031295,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"exercise","acquired":false,"shares":3272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of common stock underlying this stock option award vested in full on the one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":30.17,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":3272},"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3031294,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of common stock underlying this stock option award vested in equal quarterly installments over the first three years after the grant date."}],"balance_after":0,"derivative":{"exercise_price":32.98,"expiration_date":"2026-07-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3031293,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":200,"price":91.38,"value":18276.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.34 to $91.42 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":4422,"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3031292,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":13896,"price":90.64,"value":1259533.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.31 to $91.16 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":4622,"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3031291,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":9176,"price":89.98,"value":825656.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.31 to $90.30 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":18518,"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3031290,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"exercise","acquired":true,"shares":3272,"price":30.17,"value":98716.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":27694,"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3031289,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T16:51:24.000Z","date":"2020-09-11","kind":"exercise","acquired":true,"shares":20000,"price":32.98,"value":659600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":24422,"source":{"system":"sec-edgar","filing":"0001179110-20-009770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020009770/edgar.xml","form_type":"4"}},{"id":3150864,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-05-13T17:22:46.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":1697,"price":10.35,"value":17563.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding\nobligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1,\n2019."}],"balance_after":319847,"source":{"system":"sec-edgar","filing":"0001209191-20-028903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120028903/doc4.xml","form_type":"4"}},{"id":3238060,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-03-02T16:31:05.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":100482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to approximately 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":321544,"source":{"system":"sec-edgar","filing":"0001209191-20-014476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120014476/doc4.xml","form_type":"4"}},{"id":3249299,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-02-25T16:37:50.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":1865,"price":11.63,"value":21689.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 to $11.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":221062,"source":{"system":"sec-edgar","filing":"0001209191-20-012490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120012490/doc4.xml","form_type":"4"}},{"id":3249298,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-02-25T16:37:50.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":2312,"price":11.63,"value":26888.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 to $11.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":222927,"source":{"system":"sec-edgar","filing":"0001209191-20-012490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120012490/doc4.xml","form_type":"4"}},{"id":3300166,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-28T16:02:08.000Z","date":"2020-01-24","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":0,"derivative":{"exercise_price":10.02,"expiration_date":"2020-02-02","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-005129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120005129/doc4.xml","form_type":"4"}},{"id":3300165,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-01-28T16:02:08.000Z","date":"2020-01-24","kind":"sale","acquired":false,"shares":20000,"price":12.71,"value":254200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.33 to $12.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":225239,"source":{"system":"sec-edgar","filing":"0001209191-20-005129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120005129/doc4.xml","form_type":"4"}},{"id":3300164,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2020-01-28T16:02:08.000Z","date":"2020-01-24","kind":"exercise","acquired":true,"shares":20000,"price":10.02,"value":200400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person acquired 280 shares of Class A common stock under the issuer's employee stock purchase plan on December 31, 2019."}],"balance_after":245239,"source":{"system":"sec-edgar","filing":"0001209191-20-005129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919120005129/doc4.xml","form_type":"4"}},{"id":3302946,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-01-24T17:48:29.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":8185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest in full on the one year anniversary of the grant date."}],"balance_after":8185,"derivative":{"exercise_price":52.99,"expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":8185},"source":{"system":"sec-edgar","filing":"0001179110-20-000779","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020000779/edgar.xml","form_type":"4"}},{"id":3302945,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T17:48:29.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":1377,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4422,"source":{"system":"sec-edgar","filing":"0001179110-20-000779","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000117911020000779/edgar.xml","form_type":"4"}},{"id":3336806,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-12-18T16:37:38.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":115220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock units, granted as a special retention award, vest as to 100% of the shares of Class A Common Stock on November 18, 2021."}],"balance_after":224959,"source":{"system":"sec-edgar","filing":"0001209191-19-061135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119061135/doc4.xml","form_type":"4"}},{"id":3423284,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-04T16:42:58.000Z","date":"2019-08-30","kind":"exercise","acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":0,"derivative":{"exercise_price":4.88,"expiration_date":"2019-09-07","underlying":"Class A Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-19-048225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119048225/doc4.xml","form_type":"4"}},{"id":3423283,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-04T16:42:58.000Z","date":"2019-08-30","kind":"exercise","acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vested as to 40,000 shares of Class A common stock on each of October 24, 2011, December 21, 2012 and January 4, 2017 upon the issuer's achievement of regulatory or commercial milestones.  The remainder of the option expires on September 7, 2019."}],"balance_after":44944,"derivative":{"exercise_price":4.88,"expiration_date":"2019-09-07","underlying":"Class A Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-19-048225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119048225/doc4.xml","form_type":"4"}},{"id":3423282,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-09-04T16:42:58.000Z","date":"2019-08-30","kind":"sale","acquired":false,"shares":220000,"price":9.24,"value":2032800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":109739,"source":{"system":"sec-edgar","filing":"0001209191-19-048225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119048225/doc4.xml","form_type":"4"}},{"id":3423281,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-09-04T16:42:58.000Z","date":"2019-08-30","kind":"exercise","acquired":true,"shares":130000,"price":4.88,"value":634400.0,"ownership":{"direct":true},"balance_after":329739,"source":{"system":"sec-edgar","filing":"0001209191-19-048225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119048225/doc4.xml","form_type":"4"}},{"id":3423280,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-09-04T16:42:58.000Z","date":"2019-08-30","kind":"exercise","acquired":true,"shares":90000,"price":4.88,"value":439200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person acquired 2,500 shares of Class A common stock under the issuer's employee stock purchase plan on June 28, 2019."}],"balance_after":199739,"source":{"system":"sec-edgar","filing":"0001209191-19-048225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119048225/doc4.xml","form_type":"4"}},{"id":3527597,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-05-14T16:13:41.000Z","date":"2019-05-10","kind":"sale","acquired":false,"shares":4055,"price":10.53,"value":42699.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on July 31, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.71, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":107239,"source":{"system":"sec-edgar","filing":"0001209191-19-029609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119029609/doc4.xml","form_type":"4"}},{"id":3539872,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-05-03T16:19:22.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":45704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options, granted as a promotion grant, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of May 1, 2019."}],"balance_after":45704,"derivative":{"exercise_price":11.78,"expiration_date":"2029-05-01","underlying":"Class A Common Stock","underlying_shares":45704},"source":{"system":"sec-edgar","filing":"0001209191-19-027346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119027346/doc4.xml","form_type":"4"}},{"id":3539871,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class A Common Stock","published_at":"2019-05-03T16:19:22.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":22852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock units, granted as a promotion award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":111294,"source":{"system":"sec-edgar","filing":"0001209191-19-027346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119027346/doc4.xml","form_type":"4"}},{"id":3564771,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T18:15:06.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":504,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":80504,"derivative":{"exercise_price":12.56,"expiration_date":"2024-03-03","underlying":"Class A Common Stock","underlying_shares":504},"source":{"system":"sec-edgar","filing":"0001209191-19-023433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119023433/doc4.xml","form_type":"4"}},{"id":3564770,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T18:15:06.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":962,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":110962,"derivative":{"exercise_price":11.65,"expiration_date":"2023-02-01","underlying":"Class A Common Stock","underlying_shares":962},"source":{"system":"sec-edgar","filing":"0001209191-19-023433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119023433/doc4.xml","form_type":"4"}},{"id":3564769,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T18:15:06.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":971,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":95971,"derivative":{"exercise_price":13.11,"expiration_date":"2022-02-01","underlying":"Class A Common Stock","underlying_shares":971},"source":{"system":"sec-edgar","filing":"0001209191-19-023433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119023433/doc4.xml","form_type":"4"}},{"id":3564768,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T18:15:06.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":4988,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation.  In connection with the Separation, the number of shares subject to this option and the exercise price have been adjusted, and the reporting person received options to purchase shares of Cyclerion\nCommon Stock, to preserve the pre-Separation intrinsic value of the existing Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":99988,"derivative":{"exercise_price":9.89,"expiration_date":"2021-02-01","underlying":"Class A Common Stock","underlying_shares":4988},"source":{"system":"sec-edgar","filing":"0001209191-19-023433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000120919119023433/doc4.xml","form_type":"4"}}],"next_cursor":"2019-04-03T18:15:06.000000Z,3564768"}